UCSF

Tagged: pharmacogenomics

Study discovers why leading gout medication is ineffective for many

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Bani Tamraz, PharmD, PhD

Assistant Professor

My primary interest is identification of genetic determinants of drug response through modern methods aimed at addressing pharmacogenomics research and translating that information into new diagnostics and treatment strategies at point-of-care.

Sourav Bandyopadhyay, PhD

Professor

I seek to understand, at the systems level, how biological networks within cancer cells are fundamentally different from those in normal cells. Using a variety of experimental techniques, I design new platforms for the rational application of personalized medicine and the design of combination...

Jaekyu Shin, PharmD

Professor

I teach and precept pharmacy students and work with underserved populations at Zuckerberg San Francisco General Hospital. My research focuses on the clinical application of cardiovascular pharmacogenetic tests and pharmacoepidemiology.

Kathy Giacomini, PhD

CERSI Co-Director & Professor

My research focuses on membrane transporters, which are of great importance to drug disposition and response. I am particularly interested in genetic variants in membrane transporters that are determinants of drug response and in harnessing transporters to enhance drug targeting. 

Nadav Ahituv, PhD

Professor

My research focuses on understanding how nucleotide variation in gene regulatory elements can lead to human disease and other phenotypes. 

Child’s illness fuels lab team’s search for early-life epilepsy diagnostics

The lab of UCSF School of Pharmacy faculty member Nadav Ahituv, PhD, studies how abnormalities in DNA segments that control the activity of genes could lead to diseases.

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support

Giacomini to receive Therapeutic Frontiers Lecture Award

Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at

Pages